FNYS
BRLI

First New York Securities’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

First New York Securities’s Portfolio BRLI Stock Details BRLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-1,820
Closed -$75.1K – 566
2015
Q2 		$75.1K Buy
+1,820
New +$65.2K 0.04% 162

Other funds holding BRLI

SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

First New York Securities's BRLI Position: Q3 2015 in Review

First New York Securities sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 1,820 shares — an estimated $75.1K sold.

First New York Securities first reported a position in BRLI in Q2 2015 and held it in 1 quarter. The position peaked at $75.1K in Q2 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

  • First New York Securities reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
  • First New York Securities sold 1,820 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $75.1K.
  • First New York Securities first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2015 and held it in 1 quarter.
  • First New York Securities's BIO-REFERENCE LABS INC-NEW- position peaked at $75.1K in Q2 2015.
  • 1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on First New York Securities's 13F filing for Q3 2015, filed 27 Oct 2015.